ArticleBlood neoplasia2026

Mezigdomide combined with bortezomib disrupts the cell cycle and elicits superior antitumor effects in multiple myeloma.

Chad C Bjorklund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.